Cell Cycle / Checkpoint Control
Cyclin D1 Blocking Peptide
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #1044S | 100 μg | 16,000 | |
|
Cyclin D1抗体製品一覧
| 使用目的 | |
| Cyclin D1 (92G2) Rabbit mAb( #2978)の反応をブロックし、抗体の反応特異性を確認するために使用 |
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Cyclin D1 (92G2) Rabbit mAb #2978 in the presence of control peptide (left) or Cyclin D1 Blocking Peptide (right).
Activity of the cyclin-dependent kinases CDK4 and CDK6 is regulated by T-loop phosphorylation, by the abundance of their cyclin partners (the D-type cyclins), and by association with CDK inhibitors of the Cip/Kip or INK family of proteins (1). The inactive ternary complex of cyclin D/CDK4 and p27 Kip1 requires extracellular mitogenic stimuli for the release and degradation of p27 concomitant with a rise in cyclin D levels to effect progression through the restriction point and pRb-dependent entry into S-phase (2). The active complex of cyclin D/CDK4 targets the retinoblastoma protein for phosphorylation, allowing the release of E2F transcription factors that activate G1/S-phase gene expression (3). Levels of cyclin D protein drop upon withdrawal of growth factors through downregulation of its protein expression and through phosphorylation-dependent degradation (4).
-
Hirai, H. et al. (1995) Mol. Cell. Biol. 15, 2672-2681.
-
Sherr, C.J. (1996) Science 274, 1672-1677.
-
Lukas, J. et al. (1996) Mol. Cell. Biol. 16, 6917-6925.
-
Diehl, J.A. et al. (1997) Genes Dev. 11, 957-972.